{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:37:14Z","timestamp":1787837834517,"version":"build-2784847793"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,8]]},"DOI":"10.7759\/cureus.57877","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T01:57:16Z","timestamp":1712627836000},"source":"Crossref","is-referenced-by-count":3,"title":["Ketamine Infusion in a Resistant Obsessive-Compulsive Disorder Patient in Bangladesh with Severe Suicidal Ideation: A Case Report"],"prefix":"10.7759","author":[{"given":"Sultana","family":"Algin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debasish","family":"Banik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SM Atikur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiful","family":"Mahmud Tusher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatema","family":"Tuj Johora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha","family":"Akter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanbir","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Abdul Monib","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susmita","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mainul","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2022.152352","article-title":"Treatment-resistant OCD: pharmacotherapies in adults","volume":"120","author":"van Roessel PJ","year":"2023","unstructured":"van Roessel PJ, Grassi G, Aboujaoude EN, Mench\u00f3n JM, Van Ameringen M, Rodr\u00edguez CI. Treatment-resistant OCD: pharmacotherapies in adults. Compr Psychiatry. 2023, 120:152352. 10.1016\/j.comppsych.2022.152352","journal-title":"Compr Psychiatry"},{"key":"ref2","article-title":"Obsessive-compulsive disorder","author":"Brock H","year":"2024","unstructured":"Brock H, Hany M. Obsessive-compulsive disorder. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.48960","article-title":"Obsessive-compulsive disorder (OCD): a comprehensive review of diagnosis, comorbidities, and treatment approaches","volume":"15","author":"Singh A","year":"2023","unstructured":"Singh A, Anjankar VP, Sapkale B. Obsessive-compulsive disorder (OCD): a comprehensive review of diagnosis, comorbidities, and treatment approaches. Cureus. 2023, 15:e48960. 10.7759\/cureus.48960","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.25317","article-title":"Inflammation in obsessive-compulsive disorder: a literature review and hypothesis-based potential of transcranial photobiomodulation","volume":"102","author":"Coelho DR","year":"2024","unstructured":"Coelho DR, Salvi JD, Vieira WF, Cassano P. Inflammation in obsessive-compulsive disorder: a literature review and hypothesis-based potential of transcranial photobiomodulation. J Neurosci Res. 2024, 102:e25317. 10.1002\/jnr.25317","journal-title":"J Neurosci Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/ipj.ipj_63_16","article-title":"Depression and risk of suicide in patients with obsessive-compulsive disorder: a hospital-based study","volume":"25","author":"Chaudhary RK","year":"2016","unstructured":"Chaudhary RK, Kumar P, Mishra BP. Depression and risk of suicide in patients with obsessive-compulsive disorder: a hospital-based study. Ind Psychiatry J. 2016, 25:166-70. 10.4103\/ipj.ipj_63_16","journal-title":"Ind Psychiatry J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199211000-00010","article-title":"An epidemiological study of obsessive-compulsive disorder and related disorders in Israeli adolescents","volume":"31","author":"Zohar AH","year":"1992","unstructured":"Zohar AH, Ratzoni G, Pauls DL, et al.. An epidemiological study of obsessive-compulsive disorder and related disorders in Israeli adolescents. J Am Acad Child Adolesc Psychiatry. 1992, 31:1057-61. 10.1097\/00004583-199211000-00010","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.3804","article-title":"Suicidality in a 27-year-old male with obsessive compulsive disorder","volume":"10","author":"Ross BM","year":"2018","unstructured":"Ross BM, Lee JD, Espiridion ED. Suicidality in a 27-year-old male with obsessive compulsive disorder. Cureus. 2018, 10:e3804. 10.7759\/cureus.3804","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2017.00753","article-title":"Yes: the symptoms of OCD and depression are discrete and not exclusively negative affectivity","volume":"8","author":"Moore KA","year":"2017","unstructured":"Moore KA, Howell J. Yes: the symptoms of OCD and depression are discrete and not exclusively negative affectivity. Front Psychol. 2017, 8:753. 10.3389\/fpsyg.2017.00753","journal-title":"Front Psychol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/13651501.2017.1351991","article-title":"Relationships between obsessive-compulsive disorder, depression and functioning before and after exposure and response prevention therapy","volume":"22","author":"Motivala SJ","year":"2018","unstructured":"Motivala SJ, Arellano M, Greco RL, et al.. Relationships between obsessive-compulsive disorder, depression and functioning before and after exposure and response prevention therapy. Int J Psychiatry Clin Pract. 2018, 22:40-6. 10.1080\/13651501.2017.1351991","journal-title":"Int J Psychiatry Clin Pract"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/0269881113486718","article-title":"Two cases of delayed-onset suicidal ideation, dysphoria and anxiety after ketamine infusion in patients with obsessive-compulsive disorder and a history of major depressive disorder","volume":"27","author":"Niciu MJ","year":"2013","unstructured":"Niciu MJ, Grunschel BD, Corlett PR, Pittenger C, Bloch MH. Two cases of delayed-onset suicidal ideation, dysphoria and anxiety after ketamine infusion in patients with obsessive-compulsive disorder and a history of major depressive disorder. J Psychopharmacol. 2013, 27:651-4. 10.1177\/0269881113486718","journal-title":"J Psychopharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.690130","article-title":"Prevalence of suicidality in major depressive disorder: a systematic review and meta-analysis of comparative studies","volume":"12","author":"Cai H","year":"2021","unstructured":"Cai H, Xie XM, Zhang Q, et al.. Prevalence of suicidality in major depressive disorder: a systematic review and meta-analysis of comparative studies. Front Psychiatry. 2021, 12:690130. 10.3389\/fpsyt.2021.690130","journal-title":"Front Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2023.2833","article-title":"Determinants and outcomes of suicidal behavior among patients with major depressive disorder","volume":"80","author":"Lundberg J","year":"2023","unstructured":"Lundberg J, Cars T, Lampa E, et al.. Determinants and outcomes of suicidal behavior among patients with major depressive disorder. JAMA Psychiatry. 2023, 80:1218-25. 10.1001\/jamapsychiatry.2023.2833","journal-title":"JAMA Psychiatry"},{"key":"ref13","unstructured":"World Health Organization. Mental health and substance use. (2021). Accessed: March 23, 2024: https:\/\/www.who.int\/teams\/mental-health-and-substance-use\/data-research\/suicide-data."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1242566","article-title":"Deep brain stimulation for treatment resistant obsessive compulsive disorder; an observational study with ten patients under real-life conditions","volume":"14","author":"Abdelnaim MA","year":"2023","unstructured":"Abdelnaim MA, Lang-Hambauer V, Hebel T, et al.. Deep brain stimulation for treatment resistant obsessive compulsive disorder; an observational study with ten patients under real-life conditions. Front Psychiatry. 2023, 14:1242566. 10.3389\/fpsyt.2023.1242566","journal-title":"Front Psychiatry"},{"key":"ref15","unstructured":"World Health Organization. Suicide. (2023). Accessed: March 22, 2024: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/suicide."},{"key":"ref16","unstructured":"World Health Organization. Suicide prevention. (2023). Accessed: March 22, 2024: https:\/\/www.who.int\/health-topics\/suicide#tab=tab_1."},{"key":"ref17","article-title":"Factors associated with depression in obsessive-compulsive disorder: a cross-sectional study","volume":"52","author":"Altinta\u015f E","year":"2015","unstructured":"Altinta\u015f E, Ta\u015fkintuna N. Factors associated with depression in obsessive-compulsive disorder: a cross-sectional study. Noro Psikiyatr Ars. 2015, 52:346-53.","journal-title":"Noro Psikiyatr Ars"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2015.17.3\/ggoodwin","article-title":"The overlap between anxiety, depression, and obsessive-compulsive disorder","volume":"17","author":"Goodwin GM","year":"2015","unstructured":"Goodwin GM. The overlap between anxiety, depression, and obsessive-compulsive disorder. Dialogues Clin Neurosci. 2015, 17:249-60. 10.31887\/DCNS.2015.17.3\/ggoodwin","journal-title":"Dialogues Clin Neurosci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-020-02546-8","article-title":"Mental and somatic comorbidity of depression: a comprehensive cross-sectional analysis of 202 diagnosis groups using German nationwide ambulatory claims data","volume":"20","author":"Steffen A","year":"2020","unstructured":"Steffen A, N\u00fcbel J, Jacobi F, B\u00e4tzing J, Holstiege J. Mental and somatic comorbidity of depression: a comprehensive cross-sectional analysis of 202 diagnosis groups using German nationwide ambulatory claims data. BMC Psychiatry. 2020, 20:142. 10.1186\/s12888-020-02546-8","journal-title":"BMC Psychiatry"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2010.12.2\/dmurphy","article-title":"Obsessive-compulsive disorder and its related disorders: a reappraisal of obsessive-compulsive spectrum concepts","volume":"12","author":"Murphy DL","year":"2010","unstructured":"Murphy DL, Timpano KR, Wheaton MG, Greenberg BD, Miguel EC. Obsessive-compulsive disorder and its related disorders: a reappraisal of obsessive-compulsive spectrum concepts. Dialogues Clin Neurosci. 2010, 12:131-48. 10.31887\/DCNS.2010.12.2\/dmurphy","journal-title":"Dialogues Clin Neurosci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/neurolint13030038","article-title":"Selective serotonin reuptake inhibitors and adverse effects: a narrative review","volume":"13","author":"Edinoff AN","year":"2021","unstructured":"Edinoff AN, Akuly HA, Hanna TA, et al.. Selective serotonin reuptake inhibitors and adverse effects: a narrative review. Neurol Int. 2021, 13:387-401. 10.3390\/neurolint13030038","journal-title":"Neurol Int"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.3.522","article-title":"Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression","volume":"160","author":"Saxena S","year":"2003","unstructured":"Saxena S, Brody AL, Ho ML, Zohrabi N, Maidment KM, Baxter LR Jr. Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression. Am J Psychiatry. 2003, 160:522-32. 10.1176\/appi.ajp.160.3.522","journal-title":"Am J Psychiatry"},{"key":"ref23","article-title":"Selective serotonin reuptake inhibitors","author":"Chu A","year":"2023","unstructured":"Chu A, Wadhwa R. Selective serotonin reuptake inhibitors. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2016.115","article-title":"Suicide in obsessive-compulsive disorder: a population-based study of 36\u2009788 Swedish patients","volume":"22","author":"Fern\u00e1ndez de la Cruz L","year":"2017","unstructured":"Fern\u00e1ndez de la Cruz L, Rydell M, Runeson B, et al.. Suicide in obsessive-compulsive disorder: a population-based study of 36\u2009788 Swedish patients. Mol Psychiatry. 2017, 22:1626-32. 10.1038\/mp.2016.115","journal-title":"Mol Psychiatry"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X16666180426151746","article-title":"Diagnostic issues in early-onset obsessive-compulsive disorder and their treatment implications","volume":"17","author":"Burchi E","year":"2019","unstructured":"Burchi E, Pallanti S. Diagnostic issues in early-onset obsessive-compulsive disorder and their treatment implications. Curr Neuropharmacol. 2019, 17:672-80. 10.2174\/1570159X16666180426151746","journal-title":"Curr Neuropharmacol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4103\/psychiatry.IndianJPsychiatry_521_18","article-title":"Course and outcome of obsessive-compulsive disorder","volume":"61","author":"Sharma E","year":"2019","unstructured":"Sharma E, Math SB. Course and outcome of obsessive-compulsive disorder. Indian J Psychiatry. 2019, 61:S43-50. 10.4103\/psychiatry.IndianJPsychiatry_521_18","journal-title":"Indian J Psychiatry"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-005-0576-8","article-title":"Obsessive-compulsive syndromes and disorders: significance of comorbidity with bipolar and anxiety syndromes","volume":"255","author":"Angst J","year":"2005","unstructured":"Angst J, Gamma A, Endrass J, et al.. Obsessive-compulsive syndromes and disorders: significance of comorbidity with bipolar and anxiety syndromes. Eur Arch Psychiatry Clin Neurosci. 2005, 255:65-71. 10.1007\/s00406-005-0576-8","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp031002","article-title":"Clinical practice. Obsessive-compulsive disorder","volume":"350","author":"Jenike MA","year":"2004","unstructured":"Jenike MA. Clinical practice. Obsessive-compulsive disorder. N Engl J Med. 2004, 350:259-65. 10.1056\/NEJMcp031002","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/1744-859X-8-13","article-title":"Obsessive-compulsive disorder and related disorders: a comprehensive survey","volume":"8","author":"Fornaro M","year":"2009","unstructured":"Fornaro M, Gabrielli F, Albano C, et al.. Obsessive-compulsive disorder and related disorders: a comprehensive survey. Ann Gen Psychiatry. 2009, 8:13. 10.1186\/1744-859X-8-13","journal-title":"Ann Gen Psychiatry"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0261169","article-title":"Long durations from symptom onset to diagnosis and from diagnosis to treatment in obsessive-compulsive disorder: a retrospective self-report study","volume":"16","author":"Ziegler S","year":"2021","unstructured":"Ziegler S, Bednasch K, Baldofski S, Rummel-Kluge C. Long durations from symptom onset to diagnosis and from diagnosis to treatment in obsessive-compulsive disorder: a retrospective self-report study. PLoS One. 2021, 16:e0261169. 10.1371\/journal.pone.0261169","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5545.196976","article-title":"Clinical practice guidelines for obsessive-compulsive disorder","volume":"59","author":"Janardhan Reddy YC","year":"2017","unstructured":"Janardhan Reddy YC, Sundar AS, Narayanaswamy JC, Math SB. Clinical practice guidelines for obsessive-compulsive disorder. Indian J Psychiatry. 2017, 59:S74-90. 10.4103\/0019-5545.196976","journal-title":"Indian J Psychiatry"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1177\/070674370605100702","article-title":"The psychological treatment of obsessive-compulsive disorder","volume":"51","author":"Abramowitz JS","year":"2006","unstructured":"Abramowitz JS. The psychological treatment of obsessive-compulsive disorder. Can J Psychiatry. 2006, 51:407-16. 10.1177\/070674370605100702","journal-title":"Can J Psychiatry"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.2147\/PRBM.S211117","article-title":"Exposure and response prevention in the treatment of obsessive-compulsive disorder: current perspectives","volume":"12","author":"Law C","year":"2019","unstructured":"Law C, Boisseau CL. Exposure and response prevention in the treatment of obsessive-compulsive disorder: current perspectives. Psychol Res Behav Manag. 2019, 12:1167-74. 10.2147\/PRBM.S211117","journal-title":"Psychol Res Behav Manag"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2014.12.003","article-title":"Obsessive-compulsive disorder (OCD): practical strategies for pharmacological and somatic treatment in adults","volume":"227","author":"Fineberg NA","year":"2015","unstructured":"Fineberg NA, Reghunandanan S, Simpson HB, et al.. Obsessive-compulsive disorder (OCD): practical strategies for pharmacological and somatic treatment in adults. Psychiatry Res. 2015, 227:114-25. 10.1016\/j.psychres.2014.12.003","journal-title":"Psychiatry Res"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/s0924-9338(99)80725-1","article-title":"Citalopram for treatment-resistant obsessive-compulsive disorder","volume":"14","author":"Pallanti S","year":"1999","unstructured":"Pallanti S, Quercioli L, Paiva RS, Koran LM. Citalopram for treatment-resistant obsessive-compulsive disorder. Eur Psychiatry. 1999, 14:101-6. 10.1016\/s0924-9338(99)80725-1","journal-title":"Eur Psychiatry"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5545.192001","article-title":"Management of obsessive-compulsive disorder comorbid with bipolar disorder","volume":"58","author":"Kazhungil F","year":"2016","unstructured":"Kazhungil F, Mohandas E. Management of obsessive-compulsive disorder comorbid with bipolar disorder. Indian J Psychiatry. 2016, 58:259-69. 10.4103\/0019-5545.192001","journal-title":"Indian J Psychiatry"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2006.12.007","article-title":"Factors associated with major depressive disorder occurring after the onset of obsessive-compulsive disorder","volume":"102","author":"Besiroglu L","year":"2007","unstructured":"Besiroglu L, Uguz F, Saglam M, Agargun MY, Cilli AS. Factors associated with major depressive disorder occurring after the onset of obsessive-compulsive disorder. J Affect Disord. 2007, 102:73-9. 10.1016\/j.jad.2006.12.007","journal-title":"J Affect Disord"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.4306\/pi.2016.13.3.370","article-title":"Comorbid bipolar disorder and obsessive-compulsive disorder: an old debate renewed","volume":"13","author":"Amerio A","year":"2016","unstructured":"Amerio A, Tonna M, Odone A, Ghaemi SN. Comorbid bipolar disorder and obsessive-compulsive disorder: an old debate renewed. Psychiatry Investig. 2016, 13:370-1. 10.4306\/pi.2016.13.3.370","journal-title":"Psychiatry Investig"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.29399\/npa.27615","article-title":"Treatment of comorbid psychiatric disorders with bipolar disorder","volume":"58","author":"Altinba\u015f K","year":"2021","unstructured":"Altinba\u015f K. Treatment of comorbid psychiatric disorders with bipolar disorder. Noro Psikiyatr Ars. 2021, 58:S41-6. 10.29399\/npa.27615","journal-title":"Noro Psikiyatr Ars"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13051230","article-title":"Obsessive-compulsive disorder as an epiphenomenon of comorbid bipolar disorder? An updated systematic review","volume":"13","author":"de Filippis R","year":"2024","unstructured":"de Filippis R, Aguglia A, Costanza A, et al.. Obsessive-compulsive disorder as an epiphenomenon of comorbid bipolar disorder? An updated systematic review. J Clin Med. 2024, 13:1230. 10.3390\/jcm13051230","journal-title":"J Clin Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1990.01810180077011","article-title":"Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine","volume":"47","author":"Goodman WK","year":"1990","unstructured":"Goodman WK, Price LH, Delgado PL, et al.. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine. Arch Gen Psychiatry. 1990, 47:577-85. 10.1001\/archpsyc.1990.01810180077011","journal-title":"Arch Gen Psychiatry"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1989.01810010038006","article-title":"Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo","volume":"46","author":"Goodman WK","year":"1989","unstructured":"Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR, Charney DS. Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo. Arch Gen Psychiatry. 1989, 46:36-44. 10.1001\/archpsyc.1989.01810010038006","journal-title":"Arch Gen Psychiatry"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2014.05.006","article-title":"Pharmacological treatment of obsessive-compulsive disorder","volume":"37","author":"Pittenger C","year":"2014","unstructured":"Pittenger C, Bloch MH. Pharmacological treatment of obsessive-compulsive disorder. Psychiatr Clin North Am. 2014, 37:375-91. 10.1016\/j.psc.2014.05.006","journal-title":"Psychiatr Clin North Am"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.144.12.1543","article-title":"Fluvoxamine treatment of obsessive-compulsive disorder","volume":"144","author":"Perse TL","year":"1987","unstructured":"Perse TL, Greist JH, Jefferson JW, Rosenfeld R, Dar R. Fluvoxamine treatment of obsessive-compulsive disorder. Am J Psychiatry. 1987, 144:1543-8. 10.1176\/ajp.144.12.1543","journal-title":"Am J Psychiatry"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(90)90408-t","article-title":"Clomipramine in obsessive-compulsive disorder","volume":"28","author":"Katz RJ","year":"1990","unstructured":"Katz RJ, DeVeaugh-Geiss J, Landau P. Clomipramine in obsessive-compulsive disorder. Biol Psychiatry. 1990, 28:401-14. 10.1016\/0006-3223(90)90408-t","journal-title":"Biol Psychiatry"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2010.12.2\/mkellner","article-title":"Drug treatment of obsessive-compulsive disorder","volume":"12","author":"Kellner M","year":"2010","unstructured":"Kellner M. Drug treatment of obsessive-compulsive disorder. Dialogues Clin Neurosci. 2010, 12:187-97. 10.31887\/DCNS.2010.12.2\/mkellner","journal-title":"Dialogues Clin Neurosci"},{"key":"ref47","article-title":"Drug therapy for obsessive-compulsive disorder","volume":"48","author":"Khan SA","year":"2023","unstructured":"Khan SA. Drug therapy for obsessive-compulsive disorder. US Pharm. 2023, 48:8-12.","journal-title":"US Pharm"},{"key":"ref48","unstructured":"Medications for OCD. (2024). Accessed. March 23, 2024: https:\/\/psychiatry.ufl.edu\/patient-care-services\/ocd-program\/medications-for-ocd\/#:~:text=Although%20the%20SSRIs%20ar...."},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1093\/med-psych\/9780197552155.003.0006","article-title":"Empirically supported treatment for obsessive-compulsive disorder: core elements and adaptive applications","author":"Franklin ME","year":"2021","unstructured":"Franklin ME, Karan SG. Empirically supported treatment for obsessive-compulsive disorder: core elements and adaptive applications. Flexibility within Fidelity: Breathing Life into a Psychological Treatment Manual. Online Edition. Kendall PC (ed): Oxford Academic, New York, USA; 2021. 10.1093\/med-psych\/9780197552155.003.0006"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.5498\/wjp.v2.i6.86","article-title":"Obsessive-compulsive disorder: evidence-based treatments and future directions for research","volume":"2","author":"Lack CW","year":"2012","unstructured":"Lack CW. Obsessive-compulsive disorder: evidence-based treatments and future directions for research. World J Psychiatry. 2012, 2:86-90. 10.5498\/wjp.v2.i6.86","journal-title":"World J Psychiatry"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00093","article-title":"Editorial: advances in biological approaches to treating resistant\/refractory obsessive-compulsive and related disorders","volume":"11","author":"Pasquini M","year":"2020","unstructured":"Pasquini M, Brakoulias V, Pallanti S. Editorial: advances in biological approaches to treating resistant\/refractory obsessive-compulsive and related disorders. Front Psychiatry. 2020, 11:93. 10.3389\/fpsyt.2020.00093","journal-title":"Front Psychiatry"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1177\/2040622315579059","article-title":"Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review","volume":"6","author":"Iadarola ND","year":"2015","unstructured":"Iadarola ND, Niciu MJ, Richards EM, et al.. Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review. Ther Adv Chronic Dis. 2015, 6:97-114. 10.1177\/2040622315579059","journal-title":"Ther Adv Chronic Dis"},{"key":"ref53","article-title":"Physiology, NMDA receptor","author":"Jewett BE","year":"2022","unstructured":"Jewett BE, Thapa B. Physiology, NMDA receptor. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2022."},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.37833","article-title":"Clinical effectiveness of N-methyl-D-aspartate (NMDA) receptor antagonists in adult obsessive-compulsive disorder (OCD) treatment: a systematic review","volume":"15","author":"Ferguson AA","year":"2023","unstructured":"Ferguson AA, Khan AI, Abuzainah B, et al.. Clinical effectiveness of N-methyl-D-aspartate (NMDA) receptor antagonists in adult obsessive-compulsive disorder (OCD) treatment: a systematic review. Cureus. 2023, 15:e37833. 10.7759\/cureus.37833","journal-title":"Cureus"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.668304","article-title":"Lower ventromedial prefrontal cortex glutamate levels in patients with obsessive-compulsive disorder","volume":"12","author":"Batistuzzo MC","year":"2021","unstructured":"Batistuzzo MC, Sottili BA, Shavitt RG, et al.. Lower ventromedial prefrontal cortex glutamate levels in patients with obsessive-compulsive disorder. Front Psychiatry. 2021, 12:668304. 10.3389\/fpsyt.2021.668304","journal-title":"Front Psychiatry"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38695-z","article-title":"Cortical glutamate and GABA are related to compulsive behaviour in individuals with obsessive compulsive disorder and healthy controls","volume":"14","author":"Biria M","year":"2023","unstructured":"Biria M, Banca P, Healy MP, et al.. Cortical glutamate and GABA are related to compulsive behaviour in individuals with obsessive compulsive disorder and healthy controls. Nat Commun. 2023, 14:3324. 10.1038\/s41467-023-38695-z","journal-title":"Nat Commun"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S211703","article-title":"Investigating the role of glutamate in obsessive-compulsive disorder: current perspectives","volume":"16","author":"Karthik S","year":"2020","unstructured":"Karthik S, Sharma LP, Narayanaswamy JC. Investigating the role of glutamate in obsessive-compulsive disorder: current perspectives. Neuropsychiatr Dis Treat. 2020, 16:1003-13. 10.2147\/NDT.S211703","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200009000-00008","article-title":"Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine","volume":"39","author":"Rosenberg DR","year":"2000","unstructured":"Rosenberg DR, MacMaster FP, Keshavan MS, Fitzgerald KD, Stewart CM, Moore GJ. Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry. 2000, 39:1096-103. 10.1097\/00004583-200009000-00008","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2011.09.006","article-title":"Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment","volume":"132","author":"Pittenger C","year":"2011","unstructured":"Pittenger C, Bloch MH, Williams K. Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment. Pharmacol Ther. 2011, 132:314-32. 10.1016\/j.pharmthera.2011.09.006","journal-title":"Pharmacol Ther"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2013.150","article-title":"Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept","volume":"38","author":"Rodriguez CI","year":"2013","unstructured":"Rodriguez CI, Kegeles LS, Levinson A, et al.. Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept. Neuropsychopharmacology. 2013, 38:2475-83. 10.1038\/npp.2013.150","journal-title":"Neuropsychopharmacology"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11070856","article-title":"Therapeutic potentials of ketamine and esketamine in obsessive-compulsive disorder (OCD), substance use disorders (SUD) and eating disorders (ED): a review of the current literature","volume":"11","author":"Martinotti G","year":"2021","unstructured":"Martinotti G, Chiappini S, Pettorruso M, et al.. Therapeutic potentials of ketamine and esketamine in obsessive-compulsive disorder (OCD), substance use disorders (SUD) and eating disorders (ED): a review of the current literature. Brain Sci. 2021, 11:856. 10.3390\/brainsci11070856","journal-title":"Brain Sci"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-019-05397-8","article-title":"Ketamine induces immediate and delayed alterations of OCD-like behavior","volume":"237","author":"Thompson SL","year":"2020","unstructured":"Thompson SL, Welch AC, Iourinets J, Dulawa SC. Ketamine induces immediate and delayed alterations of OCD-like behavior. Psychopharmacology (Berl). 2020, 237:627-38. 10.1007\/s00213-019-05397-8","journal-title":"Psychopharmacology (Berl)"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-013-0056-z","article-title":"Quality of life in obsessive-compulsive disorder: impact of the disorder and of treatment","volume":"27","author":"Subramaniam M","year":"2013","unstructured":"Subramaniam M, Soh P, Vaingankar JA, Picco L, Chong SA. Quality of life in obsessive-compulsive disorder: impact of the disorder and of treatment. CNS Drugs. 2013, 27:367-83. 10.1007\/s40263-013-0056-z","journal-title":"CNS Drugs"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.17992\/lbl.2015.02.12","article-title":"Obsessive-compulsive disorder. A hidden disorder [Article in Icelandic]","volume":"101","author":"Haraldsson M","year":"2015","unstructured":"Haraldsson M. Obsessive-compulsive disorder. A hidden disorder [Article in Icelandic] . Laeknabladid. 2015, 101:87-94. 10.17992\/lbl.2015.02.12","journal-title":"Laeknabladid"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1080\/13651501.2020.1773503","article-title":"Impulsivity, hostility and suicidality in patients diagnosed with obsessive compulsive disorder","volume":"24","author":"Nagy NE","year":"2020","unstructured":"Nagy NE, El-Serafi DM, Elrassas HH, Abdeen MS, Mohamed DA. Impulsivity, hostility and suicidality in patients diagnosed with obsessive compulsive disorder. Int J Psychiatry Clin Pract. 2020, 24:284-92. 10.1080\/13651501.2020.1773503","journal-title":"Int J Psychiatry Clin Pract"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.170.3.205","article-title":"Suicide as an outcome for mental disorders. A meta-analysis","volume":"170","author":"Harris EC","year":"1997","unstructured":"Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry. 1997, 170:205-28. 10.1192\/bjp.170.3.205","journal-title":"Br J Psychiatry"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2015.03.002","article-title":"Suicidality in obsessive compulsive disorder (OCD): a systematic review and meta-analysis","volume":"39","author":"Angelakis I","year":"2015","unstructured":"Angelakis I, Gooding P, Tarrier N, Panagioti M. Suicidality in obsessive compulsive disorder (OCD): a systematic review and meta-analysis. Clin Psychol Rev. 2015, 39:1-15. 10.1016\/j.cpr.2015.03.002","journal-title":"Clin Psychol Rev"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.2147\/PRBM.S368585","article-title":"Suicidal ideation and obsessive-compulsive disorder: links and knowledge","volume":"15","author":"Benster LL","year":"2022","unstructured":"Benster LL, Weissman CR, Daskalakis ZJ. Suicidal ideation and obsessive-compulsive disorder: links and knowledge. Psychol Res Behav Manag. 2022, 15:3793-807. 10.2147\/PRBM.S368585","journal-title":"Psychol Res Behav Manag"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X16666180620155941","article-title":"Suicide risk in obsessive-compulsive disorder and exploration of risk factors: a systematic review","volume":"17","author":"Albert U","year":"2019","unstructured":"Albert U, De Ronchi D, Maina G, Pompili M. Suicide risk in obsessive-compulsive disorder and exploration of risk factors: a systematic review. Curr Neuropharmacol. 2019, 17:681-96. 10.2174\/1570159X16666180620155941","journal-title":"Curr Neuropharmacol"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.47626\/1516-4446-2022-2632","article-title":"Assessing suicide risk in patients with obsessive-compulsive disorder: a dimensional approach","volume":"45","author":"Bramante S","year":"2023","unstructured":"Bramante S, Maina G, Borgogno R, Pellegrini L, Rigardetto S, Albert U. Assessing suicide risk in patients with obsessive-compulsive disorder: a dimensional approach. Braz J Psychiatry. 2023, 45:28-37. 10.47626\/1516-4446-2022-2632","journal-title":"Braz J Psychiatry"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2017.0080","article-title":"A consensus statement on the use of ketamine in the treatment of mood disorders","volume":"74","author":"Sanacora G","year":"2017","unstructured":"Sanacora G, Frye MA, McDonald W, et al.. A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry. 2017, 74:399-405. 10.1001\/jamapsychiatry.2017.0080","journal-title":"JAMA Psychiatry"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability","volume":"46","author":"Goodman WK","year":"1989","unstructured":"Goodman WK, Price LH, Rasmussen SA, et al.. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry. 1989, 46:1006-11. 10.1001\/archpsyc.1989.01810110048007","journal-title":"Arch Gen Psychiatry"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1989.01810110054008","article-title":"The Yale-Brown Obsessive Compulsive Scale. II. Validity","volume":"46","author":"Goodman WK","year":"1989","unstructured":"Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS. The Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry. 1989, 46:1012-6. 10.1001\/archpsyc.1989.01810110054008","journal-title":"Arch Gen Psychiatry"},{"key":"ref74","article-title":"ECDEU Assessment Manual for Psychopharmacology","year":"1976","unstructured":"ECDEU Assessment Manual for Psychopharmacology. Guy W (ed). U.S. Department of Health, Education, and Welfare, Rockville, MD; 1976."},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.930812","article-title":"Use of the Depression, Anxiety and Stress Scale (DASS-21) questionnaire to assess levels of depression, anxiety, and stress in healthcare and administrative staff in 5 oncology institutions in Bosnia and Herzegovina during the 2020 COVID-19 pandemic","volume":"27","author":"Marijanovi\u0107 I","year":"2021","unstructured":"Marijanovi\u0107 I, Kraljevi\u0107 M, Buhovac T, et al.. Use of the Depression, Anxiety and Stress Scale (DASS-21) questionnaire to assess levels of depression, anxiety, and stress in healthcare and administrative staff in 5 oncology institutions in Bosnia and Herzegovina during the 2020 COVID-19 pandemic. Med Sci Monit. 2021, 27:e930812. 10.12659\/MSM.930812","journal-title":"Med Sci Monit"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1037\/\/0022-006x.47.2.343","article-title":"Assessment of suicidal intention: the scale for suicide ideation","volume":"47","author":"Beck AT","year":"1979","unstructured":"Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the scale for suicide ideation. J Consult Clin Psychol. 1979, 47:343-52. 10.1037\/\/0022-006x.47.2.343","journal-title":"J Consult Clin Psychol"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0300394","article-title":"Factors associated with suicidal ideation among medical residents in Tehran during the COVID-19 pandemic: a multicentric cross-sectional survey","volume":"19","author":"Saeed F","year":"2024","unstructured":"Saeed F, Ghalehnovi E, Saeidi M, et al.. Factors associated with suicidal ideation among medical residents in Tehran during the COVID-19 pandemic: a multicentric cross-sectional survey. PLoS One. 2024, 19:e0300394. 10.1371\/journal.pone.0300394","journal-title":"PLoS One"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.10l06653","article-title":"Rapid resolution of obsessions after an infusion of intravenous ketamine in a patient with treatment-resistant obsessive-compulsive disorder","volume":"72","author":"Rodriguez CI","year":"2011","unstructured":"Rodriguez CI, Kegeles LS, Flood P, Simpson HB. Rapid resolution of obsessions after an infusion of intravenous ketamine in a patient with treatment-resistant obsessive-compulsive disorder. J Clin Psychiatry. 2011, 72:567-9. 10.4088\/JCP.10l06653","journal-title":"J Clin Psychiatry"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2021.1061","article-title":"Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review","volume":"8","author":"Walsh Z","year":"2021","unstructured":"Walsh Z, Mollaahmetoglu OM, Rootman J, et al.. Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review. BJPsych Open. 2021, 8:e19. 10.1192\/bjo.2021.1061","journal-title":"BJPsych Open"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.3928\/00485713-20150602-06","article-title":"Glutamate modulators in the treatment of obsessive-compulsive disorder","volume":"45","author":"Pittenger C","year":"2015","unstructured":"Pittenger C. Glutamate modulators in the treatment of obsessive-compulsive disorder. Psychiatr Ann. 2015, 45:308-15. 10.3928\/00485713-20150602-06","journal-title":"Psychiatr Ann"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-023-01632-1","article-title":"Ketamine in neuropsychiatric disorders: an update","volume":"49","author":"Johnston JN","year":"2024","unstructured":"Johnston JN, Kadriu B, Kraus C, Henter ID, Zarate CA Jr. Ketamine in neuropsychiatric disorders: an update. Neuropsychopharmacology. 2024, 49:23-40. 10.1038\/s41386-023-01632-1","journal-title":"Neuropsychopharmacology"},{"key":"ref82","article-title":"Ketamine augmentation of exposure response prevention therapy for obsessive-compulsive disorder","volume":"18","author":"Bottemanne H","year":"2021","unstructured":"Bottemanne H, Arnould A. Ketamine augmentation of exposure response prevention therapy for obsessive-compulsive disorder. Innov Clin Neurosci. 2021, 18:9-11.","journal-title":"Innov Clin Neurosci"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2020.113645","article-title":"Subanesthetic ketamine infusions for suicide ideation in patients with bipolar and unipolar treatment refractory depression","volume":"296","author":"Kang MJ","year":"2021","unstructured":"Kang MJ, Kulcar E, Chandrasena R, Anjum MR, Fairbairn J, Hawken ER, Vazquez GH. Subanesthetic ketamine infusions for suicide ideation in patients with bipolar and unipolar treatment refractory depression. Psychiatry Res. 2021, 296:113645. 10.1016\/j.psychres.2020.113645","journal-title":"Psychiatry Res"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2017.03.010","article-title":"Ketamine as a rapid-acting agent for suicidal ideation: a meta-analysis","volume":"77","author":"Bartoli F","year":"2017","unstructured":"Bartoli F, Riboldi I, Crocamo C, Di Brita C, Clerici M, Carr\u00e0 G. Ketamine as a rapid-acting agent for suicidal ideation: a meta-analysis. Neurosci Biobehav Rev. 2017, 77:232-6. 10.1016\/j.neubiorev.2017.03.010","journal-title":"Neurosci Biobehav Rev"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192113792","article-title":"A pilot study of ketamine infusion after suicide attempt: new frontiers in treating acute suicidality in a real-world medical setting","volume":"19","author":"Shivanekar S","year":"2022","unstructured":"Shivanekar S, Gopalan P, Pizon A, et al.. A pilot study of ketamine infusion after suicide attempt: new frontiers in treating acute suicidality in a real-world medical setting. Int J Environ Res Public Health. 2022, 19:13792. 10.3390\/ijerph192113792","journal-title":"Int J Environ Res Public Health"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_80_21","article-title":"Antisuicidal efficacy of ketamine infusion in suicidal patients of depressive disorder","volume":"63","author":"Pathak U","year":"2021","unstructured":"Pathak U, Ahuja SK, Dwivedi R, Mishra N, Kumar P, Mishra DK, Singh R. Antisuicidal efficacy of ketamine infusion in suicidal patients of depressive disorder. Indian J Psychiatry. 2021, 63:483-9. 10.4103\/indianjpsychiatry.indianjpsychiatry_80_21","journal-title":"Indian J Psychiatry"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-015-0232-4","article-title":"Does ketamine have anti-suicidal properties? Current status and future directions","volume":"29","author":"Price RB","year":"2015","unstructured":"Price RB, Mathew SJ. Does ketamine have anti-suicidal properties? Current status and future directions. CNS Drugs. 2015, 29:181-8. 10.1007\/s40263-015-0232-4","journal-title":"CNS Drugs"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2016.16010037","article-title":"A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression","volume":"173","author":"Singh JB","year":"2016","unstructured":"Singh JB, Fedgchin M, Daly EJ, et al.. A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression. Am J Psychiatry. 2016, 173:816-26. 10.1176\/appi.ajp.2016.16010037","journal-title":"Am J Psychiatry"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2014.05.005","article-title":"Ketamine for the treatment of depression in patients receiving hospice care: a retrospective medical record review of thirty-one cases","volume":"56","author":"Iglewicz A","year":"2015","unstructured":"Iglewicz A, Morrison K, Nelesen RA, et al.. Ketamine for the treatment of depression in patients receiving hospice care: a retrospective medical record review of thirty-one cases. Psychosomatics. 2015, 56:329-37. 10.1016\/j.psym.2014.05.005","journal-title":"Psychosomatics"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.4103\/psychiatry.IndianJPsychiatry_484_18","article-title":"Efficacy of ketamine therapy in the treatment of depression","volume":"61","author":"Mandal S","year":"2019","unstructured":"Mandal S, Sinha VK, Goyal N. Efficacy of ketamine therapy in the treatment of depression. Indian J Psychiatry. 2019, 61:480-5. 10.4103\/psychiatry.IndianJPsychiatry_484_18","journal-title":"Indian J Psychiatry"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-019-0570-x","article-title":"Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression","volume":"45","author":"Phillips JL","year":"2020","unstructured":"Phillips JL, Norris S, Talbot J, et al.. Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression. Neuropsychopharmacology. 2020, 45:606-12. 10.1038\/s41386-019-0570-x","journal-title":"Neuropsychopharmacology"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.705190","article-title":"Case report: repeated series of ketamine infusions in patients with treatment-resistant depression: presentation of five cases","volume":"12","author":"Ga\u0142uszko-W\u0229gielnik M","year":"2021","unstructured":"Ga\u0142uszko-W\u0229gielnik M, W\u0142odarczyk A, Cuba\u0142a WJ, Wilkowska A, G\u00f3rska N, S\u0142upski J. Case report: repeated series of ketamine infusions in patients with treatment-resistant depression: presentation of five cases. Front Psychiatry. 2021, 12:705190. 10.3389\/fpsyt.2021.705190","journal-title":"Front Psychiatry"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102127","article-title":"Ketamine for the treatment of major depression: a systematic review and meta-analysis","volume":"62","author":"Nikolin S","year":"2023","unstructured":"Nikolin S, Rodgers A, Schwaab A, Bahji A, Zarate C Jr, Vazquez G, Loo C. Ketamine for the treatment of major depression: a systematic review and meta-analysis. EClinicalMedicine. 2023, 62:102127. 10.1016\/j.eclinm.2023.102127","journal-title":"EClinicalMedicine"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2019.04.009","article-title":"Repeated ketamine infusions for antidepressant-resistant PTSD: methods of a multicenter, randomized, placebo-controlled clinical trial","volume":"81","author":"Abdallah CG","year":"2019","unstructured":"Abdallah CG, Roache JD, Averill LA, et al.. Repeated ketamine infusions for antidepressant-resistant PTSD: methods of a multicenter, randomized, placebo-controlled clinical trial. Contemp Clin Trials. 2019, 81:11-8. 10.1016\/j.cct.2019.04.009","journal-title":"Contemp Clin Trials"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.09.007","article-title":"A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009 - January 2019","volume":"277","author":"Marcantoni WS","year":"2020","unstructured":"Marcantoni WS, Akoumba BS, Wassef M, Mayrand J, Lai H, Richard-Devantoy S, Beauchamp S. A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009 - January 2019. J Affect Disord. 2020, 277:831-41. 10.1016\/j.jad.2020.09.007","journal-title":"J Affect Disord"},{"key":"ref96","unstructured":"BioRender. (2024). Accessed. March 20, 2024: https:\/\/www.biorender.com\/."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/243777-ketamine-infusion-in-a-resistant-obsessive-compulsive-disorder-patient-in-bangladesh-with-severe-suicidal-ideation-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T01:57:26Z","timestamp":1712627846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/243777-ketamine-infusion-in-a-resistant-obsessive-compulsive-disorder-patient-in-bangladesh-with-severe-suicidal-ideation-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":96,"URL":"https:\/\/doi.org\/10.7759\/cureus.57877","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,8]]}}}